Plan-les-Ouates, Switzerland

Oliver Pohl

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Oliver Pohl

Introduction

Oliver Pohl is a notable inventor based in Plan-les-Ouates, Switzerland. He has made significant contributions to the field of medicine, particularly in the development of treatments for uterine fibroids and preterm labor. With a total of seven patents to his name, Pohl's work has the potential to impact many lives.

Latest Patents

Among his latest patents, Pohl has developed a gonadotropin-releasing hormone antagonist dosing regimen aimed at treating uterine fibroids and reducing menstrual blood loss. This invention provides compositions and methods for effectively managing menstrual blood loss in patients suffering from uterine fibroids through the administration of specific GnRH antagonists. Additionally, he has created compositions and methods for delaying the incidence of labor in pregnant subjects at risk of preterm labor. This innovative approach involves the use of nifedipine in combination with a PGF2α receptor antagonist, allowing for a more effective treatment strategy.

Career Highlights

Throughout his career, Oliver Pohl has worked with prominent companies in the pharmaceutical industry, including Obseva S.A. and Kissei Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing groundbreaking medical treatments.

Collaborations

Pohl has collaborated with esteemed colleagues such as Jean-Pierre Gotteland and Andre Chollet. These partnerships have fostered an environment of

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…